Alignment Healthcare, Inc. Stock 12‑Month Price Target Cut to $11.21, Implies 39% Upside

What happened

The average 12-month price target for Alignment Healthcare, Inc. from 12 analysts fell from $12.31 to $11.21, with forecasts ranging from $8 to $17 per share. Based on the Oct. 29 closing price, that target implies about 39% upside.

Confirmed

Global impact / market context

A lower average target means analysts on balance expect less stock price gain over the next year, which can cool investor interest. The wide $8 to $17 range shows sharp disagreement on the company's prospects, so individual analyst views matter more than the single average.

Analyst inference

The consensus rating stays 'Buy' across 16 analysts, split into 10 Buys, 6 Holds and 0 Sells, meaning most still lean positive even as the average target dropped. That gap suggests analysts see value but have trimmed expectations, a cautious rather than negative stance.

Analyst inference

What to watch

1. The average target now sits at $11.21 with a range of $8 to $17, so watch whether later analyst updates narrow that spread or pull the average further down. Confirmed
2. Watch the balance of Buy, Hold and Sell ratings; if some of the 10 Buys move to Hold, that would signal fading confidence even while the 'Buy' label holds. Analyst inference
3. Watch how the stock trades relative to the Oct. 29 closing price; a smaller gap to the $11.21 target would mean the implied 39% upside has shrunk. Analyst inference

Evidence

• Original source link unavailable